CoChat

Learning from clinical trials of neoadjuvant checkpoint blockade

Open access

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Abstract

Neoadjuvant checkpoint inhibition, in which the therapy is administered before surgery, is a promising new approach to managing bulky but resectable melanoma, and is also being explored in other cancers. This strategy has a high pathologic response rate, which correlates with survival outcomes. The fact that biopsies are routinely available provides a unique opportunity for understanding the responses to therapy and carrying out reverse translation in which these data are used to select therapies in the clinic or in trials that are more likely to improve patient outcomes. In this Perspective, we discuss the rationale for neoadjuvant immunotherapy in resectable solid tumors based on preclinical and human translational data, summarize the results of recent clinical trials and ongoing research, and focus on future directions for enhancing reverse translation.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41591-020-0829-0

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 102 references

Cited by

See all 245

Metadata

Authors
Versluis, J. M., Long, G. V., & Blank, C. U.
Affiliations
  • The Netherlands Cancer Institute (NL)
  • The University of Sydney (AU)
Corresponding author
Blank, Christian U.
Venue
Nature Medicine
Published
2020-04
Volume
26
Issue
4
Pages
475-484
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W3015451486
Cited by
234
References
102
Citations by year
2026: 29 · 2025: 49 · 2024: 48 · 2023: 41 · 2022: 33 · 2021: 23 · 2020: 11
FWCI
2.90
Type
journal article
Language
en
Licence
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by)
Funders
National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
neoadjuvant immunotherapy, immune checkpoint inhibitors, melanoma, pathological response, reverse translation, translational oncology, antitumor immunity, clinical trial design
MeSH terms
Antineoplastic Agents, Immunological, Clinical Trials as Topic, Humans, Immunotherapy, Neoplasms, Neoadjuvant Therapy, Protein Kinase Inhibitors, Cell Cycle Checkpoints

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Learning from clinical trials of neoadjuvant checkpoint blockade. https://app.cochat.ai/papers/10.1038/s41591-020-0829-0
The paper
Versluis, J. M., Long, G. V., & Blank, C. U. (2020). Learning from clinical trials of neoadjuvant checkpoint blockade. Nature Medicine. https://doi.org/10.1038/s41591-020-0829-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.